On Monday, Shares of McGraw Hill Financial Inc (NYSE:MHFI), gained 0.01% to $95.30.
S&P Capital IQ and SNL, a business unit of McGraw Hill Financial (MHFI) and a leading provider of research, analytics and data, and Deutsche Bundesbank - together with the Euro system Procurement Coordination Office (EPCO) - have signed a four-year agreement for the delivery of Standard & Poor’s Ratings Services’ credit ratings and research.
The agreement allows the central banks of the European System of Central Banks (ESCB) as members of EPCO to access a wide range of issuer credit data through S&P Capital IQ’s RatingsDirect and Xpressfeed tools, in addition to through several other market data vendors. Moreover, the agreement provides all participating central banks with the ability to share information in centralised databases - such as the ECB’s Centralised Securities Database –thereby emphasizing credit risk analysis efficiency within and across the banks. The central banks also have the opportunity to obtain access to financial fundamentals and other market data, analytics and research through S&P Capital IQ’s web-based platform.
Most banks use Standard & Poor’s data and research in their credit risk assessment processes, and risk administration, market operations, financial stability and supervisory functions. Also, as a recognised external credit assessment institution (ECAI), Standard & Poor’s’ credit ratings and research can be used by national central banks for their submission of eligible assets to the European Central Bank in exchange for credit and liquidity.
McGraw Hill Financial, Inc. provides benchmarks and ratings, analytics, data, and research services for the capital, commodities, and commercial markets worldwide. It operates in four segments: Standard & Poor’s Ratings Services (S&P Ratings), S&P Capital IQ, S&P Dow Jones Indices (S&P DJ Indices), and Commodities & Commercial (C&C).
Shares of Statoil ASA (ADR) (NYSE:STO), inclined 2.80% to $15.42, during its last trading session.
On behalf of Statoil, DNB has on 13 November 2015 purchased 717,182 shares for use in the group’s Share saving plan.
The shares have been attained at a price of NOK 129.88 per share.
Before distribution to the employees, the Share saving plan has 11,053,613 shares.
Statoil ASA, an energy company, engages in the exploration, production, transportation, refining, and marketing of petroleum and petroleum-derived products in Norway and internationally. The company operates through Development and Production Norway; Development and Production International; Marketing, Processing and Renewable Energy; and Other segments.
Finally, Shares of Exelixis, Inc. (NASDAQ:EXEL), ended its last trade with 1.48% gain, and closed at $5.48.
Exelixis, declared that Michael M. Morrissey, Ph.D., the company’s president and chief executive officer, will provide an overview of the company at Stifel’s 2015 Healthcare Conference, taking place November 17-18 in New York. The Exelixis presentation is planned for 3:00 PM EST/12:00 PM PST on Tuesday, November 17, 2015.
Exelixis, Inc., a biopharmaceutical company, develops and sells small molecule therapies for the treatment of cancer in the United States. The company offers COMETRIQ, an inhibitor of multiple receptor tyrosine kinases for the treatment of patients with progressive, metastatic medullary thyroid cancer.